Patent application number | Description | Published |
20090163500 | COMPOSITIONS AND METHODS FOR TREATING LYSOSOMAL DISORDERS - The present invention provides compositions and methods for treating lysosomal disorders using a class of substituted imidazole derivatives or compounds. | 06-25-2009 |
20120015051 | Chlorite Formulations and Methods of Preparation and Use Thereof - Described herein are chlorite formulations having a pH between about 7 and about 8.5, wherein the chlorite formulations are substantially free of deleterious non-chlorite components. Described herein are chlorite formulations, including pharmaceutical formulations, which are formulated for systemic, parenteral, or intravenous administration. Described herein are methods of preparing and methods of using the chlorite formulations described herein. | 01-19-2012 |
20120021069 | Chlorite Formulations and Methods of Preparation and Use Thereof - Described herein are chlorite formulations having a pH between about 7 and about 8.5, wherein the chlorite formulations are substantially free of deleterious non-chlorite components. Described herein are chlorite formulations, including pharmaceutical formulations, which are formulated for systemic, parenteral, or intravenous administration. Described herein are methods of preparing and methods of using the chlorite formulations described herein. | 01-26-2012 |
20120021070 | Chlorite Formulations and Methods of Preparation and Use Thereof - Described herein are chlorite formulations having a pH between about 7 and about 8.5, wherein the chlorite formulations are substantially free of deleterious non-chlorite components. Described herein are chlorite formulations, including pharmaceutical formulations, which are formulated for systemic, parenteral, or intravenous administration. Described herein are methods of preparing and methods of using the chlorite formulations described herein. | 01-26-2012 |
20120134929 | TREATMENT OF MACROPHAGE-RELATED DISORDERS - The present invention provides a method of treating a macrophage related disease comprising administering to a subject in need thereof an effective amount of an oxidative agent or an immunosuppressive agent. The present invention also provides a method of modulating macrophage accumulation or activation comprising administering to a subject in need thereof an effective amount of an oxidative agent or an immunosuppressive agent. The oxidative agent can be chlorite or a chlorite containing compound. | 05-31-2012 |
20130012539 | Compositions and Methods for Treating Lysosomal Disorders - The present invention provides compositions and methods for treating lysosomal disorders using a class of substituted imidazole derivatives or compounds. | 01-10-2013 |
20130017259 | Compositions and Methods for Treatment of Symptoms in Parkinson's Disease Patients - The invention provides dosage forms and methods utilizing nicotine to treat symptoms of a neurologic disorder. In some embodiments, the invention provides compositions for treatment of gait and balance problems associated with Parkinson's Disease. | 01-17-2013 |
20150037320 | TREATMENT OF MACROPHAGE-RELATED DISORDERS - The present invention provides a method of treating a macrophage related disease comprising administering to a subject in need thereof an effective amount of an oxidative agent or an immunosuppressive agent. The present invention also provides a method of modulating macrophage accumulation or activation comprising administering to a subject in need thereof an effective amount of an oxidative agent or an immunosuppressive agent. The oxidative agent can be chlorite or a chlorite containing compound. | 02-05-2015 |
20150044193 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF ALTERED a-SYNUCLEIN FUNCTION - Compositions and methods are provided for treating a disorder characterized by α-synuclein dysfunction and/or altered lipid metabolism. | 02-12-2015 |